JBS
JBS N.V.
JBS's fundamentals are weak: revenue fell 17% and free cash flow fell 72%, though earnings per share grew 12%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
JBS Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Healthy | |
| Under pressure | |
| Strong |
JBS's profitability and balance sheet are currently healthy, but its revenue and cash flow are under pressure.
JBS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.3x | $9.18 | -23% |
| Fair | 11x | $11.89 | -0.1% |
| Current | 11x | $11.90 | — |
| Expensive | 12x | $13.57 | +14% |
Historical ranges are pointers, not guarantees.
JBS's PE is 11x, but its earnings don't support one, so it isn't a reliable read right now.
JBS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Stable | |
| Stable | |
| Limited | |
| Low |
Analysts expect JBS's earnings, revenue and profitability to hold roughly steady. However, they disagree widely on these estimates.
JBS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $1.11 | +12% |
| Q1 2026 | $1.37 | +56% |
| Q4 2025 | $1.42 | +82% |
| Q3 2025 | $1.21 | +105% |
| Q2 2025 | $0.99 | +209% |
| Q1 2025 | $0.88 | +450% |
| Q4 2024 | $0.78 | +$0.86 |
| Q3 2024 | $0.59 | +490% |
JBS's earnings per share have fallen from their peak: $1.11 over the past year, against $1.75 in mid-2022.
JBS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.3B | -80% |
| Q1 2026 | $20B | -2.3% |
| Q4 2025 | $22.6B | +8.2% |
| Q3 2025 | $21.6B | +9.1% |
| Q2 2025 | $21.3B | +18% |
| Q1 2025 | $20.4B | +28% |
| Q4 2024 | $20.9B | +21% |
| Q3 2024 | $19.8B | +21% |
JBS's revenue is shrinking: $4.3B last quarter, down 80% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 2.5% | -2.8 points |
| Q1 2026 | 2.2% | -2.3 points |
| Q4 2025 | 4.1% | -0.7 points |
| Q3 2025 | 5.4% | -2.4 points |
| Q2 2025 | 5.3% | -0.6 points |
| Q1 2025 | 4.5% | +0.5 points |
| Q4 2024 | 4.8% | +3 points |
| Q3 2024 | 7.8% | +4.9 points |
JBS's operating margin was 2.5% last quarter, down 2.8 points from the same quarter a year ago.
JBS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $42.9M | -39% |
| Q1 2026 | -$1.3B | -$394.8M |
| Q4 2025 | $1.1B | +1.6% |
| Q3 2025 | $518.4M | -52% |
| Q2 2025 | $69.8M | -94% |
| Q1 2025 | -$857.2M | -$396.5M |
| Q4 2024 | $1.1B | +21% |
| Q3 2024 | $1.1B | +76% |
JBS still generates free cash flow, though less than at its 2020 peak: $383M over the past year.
JBS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -5.3% | -56.8M shares |
| 1 year | -54% | -1.2B shares |
| 3 years | -54% | -1.2B shares |
| 5 years | -59% | -1.5B shares |
| Available history | -62% | -1.6B shares |
JBS has 1B diluted shares, down 54% from a year ago, with $2.1B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $236.4M |
| Q3 2025 | $1.8B |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
JBS spent $2.1B buying back its own shares over the past year, after none the year before.
JBS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.7x | Very low |
| Q1 2026 | 2.9x | Moderate |
| Q4 2025 | 2.6x | Moderate |
| Q3 2025 | 2.5x | Moderate |
| Q2 2025 | 2.4x | Moderate |
| Q1 2025 | 2.6x | Moderate |
| Q4 2024 | 2.7x | Moderate |
| Q3 2024 | 2.9x | Moderate |
JBS's net debt is less than a year of its operating earnings (EBITDA), down from 2.4 years a year ago.
JBS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.6 | Neutral |
| Stochastic | 45.0 | Neutral |
JBS's weekly RSI is 41 (neutral) and its Stochastic is 45 (neutral).
JBS PE vs Consumer Defensive Sector
| Metric | JBS | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 19x | 45% below |
| PE % | 51 | 34 | 17 pts above |
JBS is trading at 11x earnings, a 45% discount to the Consumer Defensive sector's median of 19x, though its earnings don't support one.
JBS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.3 | 3.4% below |
| 20 week MA | $12.7 | 6.2% below |
| 50 week MA | $14.1 | 15% below |
JBS is in a downtrend: it's below all three of its weekly moving averages, and 15% below its 50-week average.
JBS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $13.9 | $14.6 | +5% |
| 2026 YTD | $14.6 | $11.9 | -18% |
JBS has finished every year since 2025 higher, and it's down 18% so far in 2026.